AFGGX
Price
$23.90
Change
-$0.19 (-0.79%)
Updated
Jul 10 closing price
Net Assets
125.07M
RSLAX
Price
$69.29
Change
-$0.07 (-0.10%)
Updated
Jul 10 closing price
Net Assets
94.26B
Interact to see
Advertisement

AFGGX vs RSLAX

AFGGX vs RSLAX Comparison Chart in %
View a ticker or compare two or three
VS
AFGGX vs. RSLAX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AFGGX is a StrongBuy and RSLAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RSLAX has more cash in the bank: 94.3B vs. AFGGX (125M). RSLAX pays higher dividends than AFGGX: RSLAX (0.17) vs AFGGX (0.00). AFGGX was incepted earlier than RSLAX: AFGGX (22 years) vs RSLAX (24 years). RSLAX (1.74) is less costly to investors than AFGGX (1.28). RSLAX is a more actively managed with annual turnover of: 41.00 vs. AFGGX (38.00). RSLAX has a lower initial minimum investment than AFGGX: RSLAX (250) vs AFGGX (1000). AFGGX annual gain was more profitable for investors over the last year : 26.66 vs. RSLAX (12.10). AFGGX return over 5 years is better than : 18.44 vs. RSLAX (-9.50).
AFGGXRSLAXAFGGX / RSLAX
Total Expense Ratio1.261.7472%
Annual Report Gross Expense Ratio1.281.7474%
Fund Existence22 years24 years-
Gain YTD17.79211.593153%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets125M94.3B0%
Annual Yield % from dividends0.000.17-
Returns for 1 year26.6612.10220%
Returns for 3 years47.9426.26183%
Returns for 5 years18.44-9.50-194%
Returns for 10 years63.4667.5194%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FRIAX2.52N/A
N/A
Franklin Income Adv
GSMYX25.93N/A
N/A
Goldman Sachs Small/Mid Cap Growth Instl
RLAIX24.27N/A
N/A
T. Rowe Price Latin America I
BDBPX32.05N/A
N/A
iShares Russell 2000 Small-Cap Idx Inv P
MCYCX15.72-0.49
-3.02%
NYLI Candriam Emerging Markets Eq Cl C